Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events

NCT05333068 is registered in ClinicalTrials.gov with Diagram B.V. as lead sponsor.

NCT NCT05333068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05333068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
Lead sponsor
Diagram B.V.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 16, 2022
Completion date
December 31, 2026
Enrollment
1,223 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ischemia, multivessel coronary artery disease, vulnerable plaque